Viewmind

About:

Digital Biomarker / AI Software for the early detection of Alzheimer and MCI

Top Investors: Cites, Mark Edwards

Description:

ViewMind is a digital health and artificial intelligence company. It analyzes eye movement patterns using its AI-powered comprehensive neurocognitive health assessments. To detect and track Alzheimer's disease and other neurocognitive problems, ViewMind uses eye movement monitoring to acquire the most accurate type of brain health data.

Total Funding Amount:

$1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Alpine, New Jersey, United States

Founded Date:

2016-01-01

Contact Email:

mark.edwards(AT)viewmind.ai

Founders:

Gerardo Fernandez, Mark Edwards

Number of Employees:

1-10

Last Funding Date:

2020-09-01

IPO Status:

Private

Industries: